Oliver Plettenburg

Prof. Oliver Plettenburg holds a Professorship at the Institute of Organic Chemistry within the Faculty of Natural Sciences at Leibniz University Hannover. His primary research focuses on medicinal chemistry, drug discovery, and nanotechnology applications in biomedical contexts. He is affiliated with the Medicinal Chemistry Group and contributes to the Examination Board for Chemistry (B.Sc./M.Sc.).

His research interests span drug design targeting metabolic disorders, cancer therapies, and molecular imaging technologies. Notable projects include developing optoacoustic imaging agents, peptide-based drugs for cachexia, and inhibitors of protein-protein interactions for parasitic diseases. His work frequently integrates organic synthesis with biological applications, such as enzyme electrode fabrication and nanoparticle therapy.

Prof. Plettenburg has co-authored over 70 publications since 1999, including high-impact studies in Nature Metabolism, Journal of Medicinal Chemistry, and ACS Applied Materials & Interfaces. His lab collaborates extensively with institutions in Germany and internationally, focusing on translating chemical innovations into clinical applications.

Awards and recognitions are not explicitly listed in the provided texts, though his sustained contributions to drug discovery research indicate significant academic impact. His group actively engages in interdisciplinary projects bridging organic chemistry, pharmacology, and biomedical engineering.